Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Oropharyngeal Neoplasms 5Lung Neoplasms 5Mouth Neoplasms 4Mesothelioma, Malignant 4Laryngeal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma 4Urinary Bladder Neoplasms 3Nasopharyngeal Carcinoma 3Lymphoid Interstitial Pneumonia 3Hypopharyngeal Neoplasms 3Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Ganglioneuroblastoma 2Cholangiocarcinoma 2Adenocarcinoma of Lung 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Solitary Fibrous Tumor, Pleural 1Small Cell Lung Carcinoma 1Sinonasal Squamous Cell Carcinoma 1Salivary Gland Neoplasms 1Resectable Intrahepatic Cholangiocarcinoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Osteosarcoma 1

Interventions

X-Rays 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Nuclear Medicine Department, Hospital 4Cyclophosphamide 4fludarabine 3Specimen Handling 3Gemcitabine 3Doxorubicin 3Biopsy 3ulixertinib 2tipifarnib 2selpercatinib 2olaparib 2larotrectinib 2ivosidenib 2ensartinib 2cabozantinib 2Methotrexate 2Mesna 2Ifosfamide 2Eflornithine 2Cisplatin 2tazemetostat 1talazoparib 1selinexor 1pazopanib 1palbociclib 1mifamurtide 1merphos 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Platinum × 30 days × Clear all
NCT05691478 2026-06-03

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

National Cancer Institute (NCI)

Phase 2/3 Recruiting
1,122 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡